Hot Jobs

Looking for Career in Pharmacovigilance/ Clinical Research. Enter details here.

Sunday, 27 April 2014

Senior Research Associate/ Research Scientist- Biology @ Syngene International Private Limited,Bengaluru"P"

Job Description




Qualification:-Masters (M.Sc./M.Pharm./M.V.Sc) with 1-5 years of experience from reputed universities/pharma companies
Experience:-
Strong scientific and technical knowledge in cell or molecular biology and biochemistry or related areas.
The incumbent should have hands on experience in cell culture, molecular biology and biochemistry techniques. In vivo experience is desirable.
Location: Bangalore
Job Code: NA
Job Profile:
The incumbent is expected to conduct the in vitro /ex vivo mechanistic studies, biochemical estimations.
Capable of developing new assays or models in the department. Should be well versed with statistical analysis and data interpretation.
Should be analytical in thinking and work with a focused approach.
Need good written and oral communication skills. Should be a Good team player


Skills Set:
Cell culture: maintenance and handling of multiple cell lines, cell based assays, primary culture of cells.
Biochemistry and molecular biology techniques: RNA /DNA isolation, qPCR, transfection, western blotting, protein qunatitation, and relevant techniques

Desired Candidate Profile

Education:
UG - B.Sc - Any Specialization, B.Pharma - Pharmacy, B.Tech/B.E. - Any Specialization, BVSC - Veterinary Science
PG - M.Sc - Bio-Chemistry, Biology, Chemistry, M.Pharma - Pharmacy, M.Tech - Any Specialization, MVSC - Veterinary Science
Doctorate - Doctorate Not Required


Qualification:-Masters (M.Sc./M.Pharm./M.V.Sc) with 1-5 years of experience from reputed universities/pharma companies
Experience:-
Strong scientific and technical knowledge in cell or molecular biology and biochemistry or related areas.
The incumbent should have hands on experience in cell culture, molecular biology and biochemistry techniques. In vivo experience is desirable.

CLICK HERE FOR MORE INFO

No comments:

Post a Comment

Subscribe to us